WHI5 is a transcriptional repressor that delays the G1/S transition by inhibiting SBF (SCB-binding factor) transcriptional activity until cells reach a critical size . Its regulation involves phosphorylation, dilution during cell growth, and interactions with cyclin-dependent kinases (CDKs) .
Phosphorylation sites: 19 identified sites, including 12 CDK sites and 6 non-CDK sites .
Nuclear localization: Exported to the cytoplasm in late G1 via phosphorylation-dependent mechanisms .
| Epitope/Tag | Application | Citations |
|---|---|---|
| HA (3×HA) | Western blot, immunoprecipitation | |
| Myc (13×Myc) | Western blot, phosphatase assays | |
| GFP | Live-cell microscopy | |
| mCherry | Single-cell fluorescence tracking |
WHI5 is synthesized during S/G2/M and diluted during G1 as cells grow . Studies confirm:
Hyper-phosphorylation by Cln1/2-Cdk1 in late G1 inactivates WHI5 .
Mutation of phosphorylation sites (e.g., S78) disrupts cell cycle progression .
Nuclear export: Phosphorylated WHI5 is exported via Msn5/Swi6 pathways .
Cdk1 activity: Antibodies detect hyper-phosphorylated WHI5 in late G1 .
WHI5 is a transcriptional repressor that plays a crucial role in regulating the expression of genes involved in the G1 phase of the cell cycle. It acts by negatively regulating G1-specific transcription driven by the SBF and MBF transcription factors. WHI5 binds to the promoters of G1-specific genes through its interaction with SBF, repressing transcription in early G1. As the cell progresses through G1, WHI5 undergoes phosphorylation by cyclin-dependent kinases (CDKs), initially by CLN3-CDC28 and subsequently by other G1-cyclins. This phosphorylation cascade leads to the dissociation of WHI5 from SBF, thereby activating SBF-dependent transcription in late G1. When the cell enters mitosis, the mitotic exit network (MEN) deactivates CDK activity, allowing WHI5 to reassociate with SBF and re-establish repression of G1/S transcription.
KEGG: sce:YOR083W
STRING: 4932.YOR083W
WHI5 functions as a cell cycle transcriptional repressor in yeast species. In Saccharomyces cerevisiae (baker's yeast), it acts specifically as a G1-specific transcriptional repressor (WHI5 YOR083W YOR3116W), while in Schizosaccharomyces pombe (fission yeast), it functions as a cell cycle transcriptional repressor and is also known as meiotically up-regulated gene 54 protein (mug54 SPBC800.02) . WHI5 plays a crucial role in cell cycle regulation, particularly in the control of the cell cycle transition known as "Start" in the G1 phase. This transition couples cell growth to cell cycle progression, ensuring appropriate timing of cell division .
Currently, researchers have access to multiple WHI5 antibody products, primarily rabbit polyclonal antibodies with specificity for different yeast species:
Rabbit anti-Saccharomyces cerevisiae (strain 204508/S288c) WHI5 Polyclonal Antibody - Specifically targets the G1-specific transcriptional repressor WHI5 in baker's yeast
Rabbit anti-Schizosaccharomyces pombe (strain 972/24843) WHI5 Polyclonal Antibody - Targets the cell cycle transcriptional repressor whi5 in fission yeast
Both antibodies are antigen-affinity purified with IgG isotype and have been validated for applications including ELISA and Western Blot analysis .
WHI5 protein structure has been analyzed using various computational tools. Research indicates that WHI5 may belong to the category of intrinsically unstructured proteins, as determined through charge-hydropathy (CH) plot analysis. This method specifically localizes natively unfolded proteins within a defined region of CH space separated from structured proteins by a linear boundary defined by the equation: ⟨q⟩ = 2.785⟨H⟩−1.151, where ⟨H⟩ represents mean hydrophobicity and ⟨q⟩ the mean net charge .
The structural characteristics of WHI5 have been assessed using multiple neural network predictors, including:
PONDR-FIT: a meta-predictor integrating outputs from six different disorder predictors
Additionally, researchers have calculated key physicochemical parameters such as isoelectric points using ProtParam and grand average of hydropathy (GRAVY) values to further characterize WHI5 structure .
WHI5 antibodies have been validated for the following applications:
Enzyme-Linked Immunosorbent Assay (ELISA/EIA) - For quantitative detection of WHI5 protein in complex samples
Western Blot (WB) analysis - For identification and semi-quantitative analysis of WHI5 protein in cell lysates
When employing these antibodies, researchers should ensure proper identification of the antigen by confirming the expected molecular weight and expression pattern. Cross-reactivity testing with related proteins is recommended to validate specificity, especially when working with novel experimental conditions or sample types.
For recombinant WHI5 protein production, the following methodology has been validated:
Transform expression plasmids into appropriate E. coli strains
Grow bacterial cultures until an OD600 of 0.5 is reached
Induce protein expression with 200 mM IPTG at 30°C for 2 hours
Harvest cells by centrifugation
Resuspend cell pellet in 1/200 volume of lysis buffer (50 mM Na₂HPO₄, pH 8.0, 300 mM NaCl) containing 10 mM imidazole and protease inhibitors cocktail
Process immediately or store at -20°C
Perform protein extraction followed by immobilized metal affinity chromatography (IMAC) purification on Ni²⁺/NTA beads
Elute recombinant WHI5 in lysis buffer containing 250 mM imidazole
This protocol has been successfully used for producing recombinant Whi5 from Saccharomyces cerevisiae (Whi5 Sc) and can be adapted for other species with appropriate modifications to expression conditions.
Computational methods can significantly enhance antibody research through:
Structure prediction - Accurately predicting antibody structures from sequences (comparative protein modeling) when experimental structure determination is challenging or expensive
Antibody-antigen docking simulation - Predicting complex structures when binding interactions are unknown
Affinity improvement - Using computational methods to predict mutations that may enhance binding affinity, specificity, or properties like solubility
Importantly, successful computational antibody design does not necessarily require high-resolution crystal structures. Moderate resolution structures (2.17 to 2.80 Å) or even homology models have been successfully used as starting points for computational design . Computational protein-protein docking, especially when guided by experimental data, can serve as an effective first step in the design procedure.
The dynamics of WHI5 concentration throughout the cell cycle has been a subject of scientific debate. Several research groups, including Schmoller et al., have observed that WHI5 protein concentration decreases (dilutes) during the pre-Start G1 phase of the cell cycle . This dilution occurs because WHI5 mRNA is only weakly expressed during G1, while cell growth continues, leading to a decrease in protein concentration.
This pattern reflects the transcriptional regulation of WHI5, with weak expression in G1 leading to dilution, followed by strong synthesis in the budded phase of the cell cycle. This dilution mechanism has been verified through:
Live-cell wide-field fluorescence microscopy of tagged WHI5 in asynchronously cycling cells
Immunoblot analysis of G1-arrested cells
Elutriation experiments showing decreased WHI5:Cln3 ratio as cells grow through G1 phase
WHI5 plays a critical role in coupling cell growth to cell cycle progression in budding yeast. The pre-Start G1 duration is highly variable, but on average, smaller-born cells spend more time in pre-Start G1 before entering their first cell cycle . This mechanism helps maintain appropriate cell size control across generations.
One proposed mechanism involves the dilution of WHI5 during G1. As cells grow in G1, the concentration of WHI5 decreases due to limited synthesis, eventually reaching a threshold that permits cell cycle entry. This model suggests that WHI5 dilution serves as a molecular ruler that measures cell growth during G1 and triggers Start when sufficient growth has occurred .
WHI5 has been studied in comparison to retinoblastoma (Rb) proteins, revealing important similarities and differences. Both WHI5 and Rb function as transcriptional repressors involved in cell cycle regulation, specifically controlling the G1-to-S phase transition .
Structural analysis using computational tools reveals distinctive characteristics of WHI5:
WHI5 appears to belong to the category of intrinsically unstructured proteins based on charge-hydropathy plot analysis
Prediction tools such as PONDR-FIT and VSL2B help characterize the disordered regions of WHI5
WHI5 homologs have been identified using Pfam and BLASTP searches, allowing for comparative structural analysis
This comparative approach provides insights into the evolutionary relationships between cell cycle regulators across different species and helps understand the conserved mechanisms of cell cycle control.
The scientific literature presents contradictory findings regarding WHI5 concentration dynamics during G1 phase:
Supporting WHI5 dilution:
Schmoller et al. observed WHI5 dilution in G1 using live-cell fluorescence microscopy with careful background and autofluorescence subtraction
Multiple independent laboratories confirmed this dilution phenomenon using different strains, microscopes, and analysis methods
Immunoblot analysis of G1-arrested cells demonstrated WHI5 dilution
Elutriation experiments showed decreased WHI5:Cln3 ratio during G1 growth
Sommer et al. confirmed that "Whi5 concentration decreased by ~30% in rich carbon and 20% in poor carbon"
Opposing WHI5 dilution:
Litsios et al. and Dorsey et al. reported constant WHI5 concentrations during G1
Litsios suggested that reported changes might be attributed to photobleaching artifacts
These contradictions highlight the challenges in measuring protein concentrations in live cells and emphasize the importance of appropriate controls and methodological rigor in such studies.
Several methodological factors may contribute to the contradictory findings regarding WHI5 concentration dynamics:
Background subtraction: Proper subtraction of background and cell autofluorescence is critical before extracting the total fluorescence intensity of tagged WHI5 as a proxy for protein amount
Photobleaching controls: Schmoller et al. performed specific control experiments that excluded photobleaching as the cause of observed WHI5 concentration decrease during G1
Imaging frequency: Different imaging intervals may impact the detection of concentration changes, especially if the changes are subtle
Cell segmentation methods: Differences in cell volume estimation based on cell segmentations obtained from phase contrast images could affect concentration calculations
Strain differences: Genetic background variations might influence WHI5 expression patterns
Growth conditions: Nutrient availability and growth rates can impact protein synthesis and dilution dynamics
Resolving these contradictions requires careful experimental design with appropriate controls for each potential confounding factor.
When designing fluorescence microscopy experiments to study WHI5 dynamics, researchers should include the following controls:
Photobleaching controls: Perform control experiments with modified imaging frequencies to quantify and account for photobleaching effects
Background fluorescence assessment: Measure and subtract background fluorescence and cellular autofluorescence from the total signal
Strain validation controls: Include untagged wild-type strains to establish baseline fluorescence levels
Cell cycle markers: Use additional fluorescent markers to clearly identify cell cycle phases
Fixation controls: Compare live-cell imaging with fixed-cell imaging to assess potential artifacts from live imaging
Multiple tagging strategies: Use different fluorescent tags and tagging positions to ensure tag-independent observations
Cross-validation: Verify fluorescence microscopy results with orthogonal methods such as immunoblotting or flow cytometry
These controls help ensure that observed changes in WHI5 concentration are biologically meaningful rather than technical artifacts.
For researchers employing computational approaches to study WHI5 structure and function, the following methodological considerations are recommended:
Multiple prediction tools: Utilize multiple computational tools (e.g., PONDR-FIT, VSL2B) rather than relying on a single prediction method
Parameter selection: Calculate relevant physicochemical parameters including isoelectric points and GRAVY values using established tools like ProtParam
Homology analysis: Identify and analyze WHI5 homologs using both Pfam and BLASTP searches to gain evolutionary insights
Motif analysis: Apply algorithms like MEME to analyze protein sequences for similarities and produce visual descriptions of discovered motifs
Structural modeling validation: When predicting structures, validate computational models against available experimental data whenever possible
By employing these methodological approaches, researchers can generate robust computational models that enhance our understanding of WHI5 structure and function while minimizing artifacts and misinterpretations.